Screener
Amylyx Pharmaceuticals, Inc. AMLX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026. Open the filing →
- Filed
- Mar 3, 2026, 7:10 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-086645
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s free cash flow?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported free cash flow of -$27.99M in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s free cash flow increased by 52.6% year-over-year, from -$59.03M to -$27.99M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s free cash flow has grown at a 13.2% compound annual growth rate (CAGR), from -$75.15M to -$123.48M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude